Tuesday, June 7, 2011

Complimentary Webinar - Going Global: Partnering and Investing in International Life Sciences
Sponsored by MERRILL DATASITE®


Share | Facebook Twitter LinkedIn Email a Colleague

 

Whether pharmaceutical, bio-pharmaceuticals, medical devices or diagnostics, virtually every company in the Life Sciences is looking for international partnerships. In addition to traditional factors such as market size, life science companies must also consider key factors such as technology fit and the assets/scale of potential partners to allow for effective product commercialization.


Come learn from seasoned experts how knowledge about a potential partner’s innovations is essential, how to identify and evaluate prospective partners and effectively size market potential, why focus should center on individual countries rather than regions and how to identify and mitigate commercial risk. A checklist for partnering and investing internationally, illustrated with recent real-world examples, will be provided.


Moderator David Yeary of Merrill’s Datasite will lead a 90-minute discussion with Jim Weissman, Vice President of Business Development, MannKind Corporation, and Yali Friedman, Ph.D., founder of thinkBiotech. They will cover how technology has helped MannKind accomplish their international licensing goals, both efficiently and securely, as well as touch on many hot topics in biotechnology entrepreneurship.


During this webinar, you will learn:

  • What Life Sciences companies must do before they start the licensing/partnering process
  • How to find the most appropriate global partner for your asset
  • What information do you need to communicate to potential global partners?
  • How to organize data to communicate effectively with global partners
  • How to identify and manage the risks of global partnerships
  • What lessons can we learn and how to avoid pitfalls

The experts will also answer your team's questions during the Q&A.

 

Speakers
Yali Friedman, PhD

Yali Friedman, PhD Founder

thinkBiotech

Yali Friedman, Ph.D., is Founder of thinkBiotech. His book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. Dr. Friedman also has strong exposure to leading issues in international biotechnology. Dr. Friedman teaches biotechnology management at the NIH and regularly guest-lectures for other biotechnology education programs, and writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
Jim Weissman

Jim Weissman Vice President of Business Development

MannKind

As Vice President of Business Development for MannKind, Jim Weissman leads MannKind's strategic alliance and licensing partnership efforts. He brings over 20 years of experience in general management, business development, and marketing in biotech and pharmaceuticals having worked in senior management positions at Pharmacia and Pfizer. Weissman served as the General Manager for Pharmacia Biotech UK & Ireland where he headed country operations including sales, marketing, customer support, and operations. He also served as the Director of Business Development for Pfizer Japan where he headed the New Product Planning, Licensing, and Corporate Strategic Planning Departments. Weissman received his B.S. in Chemistry from Bates College and has extensive international experience having lived and worked in Europe for 5 years and Japan for 11 years prior to returning to the USA in 2006.
David Yeary

David Yeary Moderator

Merrill Corporation

David Yeary is the Vice President of Sales-Life Sciences for Merrill’s DataSite. Most recently, Mr. Yeary worked at Morgan Lewis as Director, Business and Practice Development where he assisted and lead business development opportunities in Life Sciences, Technology, Clean Tech and Digital Media and Entertainment. He also worked with private equity, venture capital and investment banks to bridge between client and investor. Mr. Yeary gained his experience at Synarc, Celera, IMS, Agouron/Pfizer and Roche/Syntex in various business development, sales and marketing roles. He has and continues to work with numerous startups as an advisor for business development, commercialization and marketing and communication functions. Periodically he can be heard on the radio or speaking at Stanford discussing the challenges and opportunities for the new entrepreneur. He holds a BS and MBA in business from California State University, Fresno.